AlphAIAlphAI — Financial news for AI agents
marketscreener.comOCT 91 min read$CME

Morgan Stanley Adjusts Price Target on CME Group to $337 From $330

Morgan Stanley raised its price target for CME Group from $330 to $337. The stock has seen a 5-day change of 2.28% and a 1st Jan change of 4.28%. The adjustment is based on the firm's valuation and EPS revisions.

Original reporting
marketscreener.com
Published Oct 9, 2026, 10:23 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 10:50 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefFinancial news
Primary signal
$CME
Bullish
high confidence
Mentioned
$CME
Relevance
6/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$CMEBullishMed
01

Why it matters

The upward revision may prompt short‑term buying and influence analyst consensus on CME.

02

Market read

Analyst price target changes are a common catalyst for short‑term price moves, especially for a market‑leading exchange.

03

What to watch

Potential regulatory changes to derivatives markets could offset the bullish thesis.

Relevance 6/10Novelty 6/10Timing: pre‑market today

Background

Morgan Stanley's research team adjusted its valuation model for CME Group, reflecting recent earnings trends and market dynamics.

Company-level read

Ticker impact

$CMEBullishHigh confidence
Context

Morgan Stanley raised its price target for CME Group to $337 from $330.

Expected impact

likely modest upside as investors price in the higher target

Evidence & confidence

Target raise reflects improved earnings expectations and market positioning, prompting buying pressure.

Market effects

Sector

Higher target may lift sentiment for the broader financial services and exchange sector.

Regional

U.S. equity markets could see slight positive bias in the financials segment.

Global

Limited to investors tracking U.S. exchange operators.

Counterpoint

What could challenge this read

Target raise could be premature if macro volatility persists, suggesting caution.

Key entities

  • Research Firm
    Morgan Stanley

    Issuer of the new price target.

  • Company
    CME Group

    U.S.-listed exchange operator.

Read at source← All news

Related articles

OCT 11
$CMEMed

FanDuel Gets FCM License, Raising Questions Over CME Role in Predicts

FanDuel has received a futures commission merchant (FCM) license from the National Futures Association, allowing it more control over its U.S. prediction market business. The approval raises questions about its partnership with CME Group, which holds a 51% stake in FanDuel Predicts. CME's CEO previously stated that such a license could conflict with their agreement. FanDuel's new license does not permit it to operate its own exchange, but it may seek further approvals in the future.

bonus.com2 min
OCT 8
$CMEMed

Baseball may get its first stats-based trading contracts Oct. 12, pending regulatory review.

CME Group plans to launch baseball futures on October 12, 2026, pending regulatory approval. The contracts will track CME FutureSports Performance Indexes, based on official league data of 30 professional baseball teams. Standard contracts will be valued at 10x the indexes, while micro contracts will be 1/10 their value. Trading will begin with the 2026 Postseason and the four clubs in the League Championship Series.

stocktitan.net2 min
OCT 7
$FLUTHigh

FanDuel Lands FCM License, But CME Isn’t Involved

FanDuel, owned by Flutter Entertainment (FLUT), secured a futures commission merchant (FCM) license from the National Futures Association. This approval may alter FanDuel's relationship with CME Group (CME), the majority owner of FanDuel Predicts. FanDuel has been expanding its prediction market operations, including a partnership with Crypto.com. CME has expressed concerns about FanDuel's potential competitive threat.

casino.org2 min